← All Sponsors
SPONSOR

Rina Plattner

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Metastatic MelanomaBRAF Gene Mutation
NCT04903119 Phase 1
Recruiting

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

Metastatic Melanoma
United States View Trial →